Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009928 |
---|---|
Receipt number | R000011634 |
Scientific Title | ECRIPS: Phase II study of docetaxel, cisplatin and cetuximab (TPE) followed by cetuximab with Concurrent Radiotherapy in Patients with local advanced Squamous cell carcinoma of the Head and Neck (LA-SCCHN). |
Date of disclosure of the study information | 2013/03/10 |
Last modified on | 2018/10/03 17:09:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/02/01 15:19:53 | ||
2 | Update | 2013/04/15 16:19:11 | UMIN ID1 |
|
3 | Update | 2013/04/16 15:28:19 | Public title Acronym Acronym |
|
4 | Update | 2013/04/16 16:48:58 | Narrative objectives1 Trial characteristics_1 Developmental phase |
|
5 | Update | 2013/04/16 21:50:58 | Type of intervention Interventions/Control_1 Key exclusion criteria Key exclusion criteria |
|
6 | Update | 2013/04/16 22:01:38 | TEL Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Institute Institute Organization Organization Nationality of Funding Organization Nationality of Funding Organization Research ethics review |
|
7 | Update | 2013/04/16 22:31:14 | Primary outcomes Key secondary outcomes Key secondary outcomes |
|
8 | Update | 2013/04/16 22:35:08 | Control Key exclusion criteria |
|
9 | Update | 2013/08/01 14:16:20 | UMIN ID2 |
|
10 | Update | 2013/08/02 13:42:07 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
11 | Update | 2014/01/17 10:44:09 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
12 | Update | 2014/01/17 10:58:12 | Recruitment status |
|
13 | Update | 2016/03/01 14:12:07 | Recruitment status |
|
14 | Update | 2016/08/04 09:31:23 | Email Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information TEL Name of primary person or sponsor Organization |
|
15 | Update | 2016/11/15 09:31:13 | Institutions |
|
16 | Update | 2016/11/15 09:33:43 | Last follow-up date |
|
17 | Update | 2017/08/07 09:56:00 | Date trial data considered complete Date analysis concluded |
|
18 | Update | 2018/10/03 17:08:52 | Public title |
|
19 | Update | 2018/10/03 17:09:07 | Recruitment status |